Urinary Retention: Clinical Trials

5 trials for Urinary Retention, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 2, 2 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Completed 5
Phase 12Completed 2
Phase 32Completed 2

Follow Urinary Retention: new trials by email Literature Review of Urinary Retention trials Research Report on Urinary Retention

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intravesical Antifibrinolytic for Patients With Hematuria and Clot Retention
Tranexamic acid - Urologic Diseases, Prostate Cancer
Phase 1 / Phase 2CompletedFraser Health142021-03-012021-11-05
Prophylactic Administration of Alpha Blockers for Prevention of Urinary Retention in Males Undergoing Inguinal Hernia Repair Under Spinal Anaesthesia.
Tamsulosin, Placebo oral tablet - Inguinal Hernia, Urinary Retention
Phase 1 / Phase 2CompletedGeorgios Koukoulis1002020-02-012021-11-26
Tamsulosin vs Placebo to Prevent Postoperative Urinary Retention in Female Pelvic Reconstructive Surgery
Placebo oral capsule, Tamsulosin - Urinary Retention, Lower Urinary Tract Symptoms
Phase 2 / Phase 3CompletedUniversity Hospitals Cleveland Medical Center1322018-08-012021-11-08
Botulinum Toxin A Injections in Patients With Fowler's Syndrome
onabotulinumtoxinA - Urinary Retention, Fowler's Syndrome
Phase 2 / Phase 3CompletedUniversity College, London102009-11-012015-04-29
Self Management in Urinary Catheter Users
Self-management of urinary catheter - Urinary Retention, Neurogenic Bladder
Phase 2CompletedUniversity of Rochester2022009-06-012012-09-18

Narrower conditions

Chronic Disease (1)  ·  Fowler Christmas Chapple syndrome (1)  ·  Hematuria (1)  ·  Hernia, Inguinal (1)  ·  Lower Urinary Tract Symptoms (1)  ·  Patient Satisfaction (1)  ·  Pelvic Organ Prolapse (1)  ·  Prostatic Neoplasms (1)  ·  Urinary Bladder Neoplasms (1)  ·  Urinary Bladder, Neurogenic (1)  ·  Urinary Incontinence, Stress (1)  ·  Urologic Diseases (1)

Broader conditions

Female Urogenital Diseases (5)  ·  Female Urogenital Diseases and Pregnancy Complications (5)  ·  Male Urogenital Diseases (5)  ·  Urination Disorders (5)  ·  Urogenital Diseases (5)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Urologic Diseases (4)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Anatomical (2)  ·  Signs and Symptoms (2)  ·  Urinary Bladder Diseases (2)  ·  Behavior (1)  ·  Disease Attributes (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Male (1)

Interventions

Tamsulosin (2)  ·  Blood Glucose Self-Monitoring (1)  ·  Botulinum Toxins, Type A (1)  ·  Self-Management (1)  ·  Tranexamic Acid (1)

Sponsors

Fraser Health (1)  ·  Georgios Koukoulis (1)  ·  University College, London (1)  ·  University Hospitals Cleveland Medical Center (1)  ·  University of Rochester (1)

Countries

United States (2)  ·  Canada (1)  ·  Greece (1)

Top investigators

Ali Abdalvand, MD (1)  ·  Georgios D Koukoulis, MD, PhD (1)  ·  Graham Chapman (1)  ·  Konstantinos Mpouliaris, MD (1)  ·  Konstantinos Tepetes, MD, PHD (1)  ·  Mary H. Wilde, RN, PhD (1)

Results publications

PMID 11743295, PMID 15291863, PMID 25502058, PMID 26938358, PMID 33894146

NIH funding

R01NR010553 (1)